Chitooligosaccharides Derivatives Protect ARPE-19 Cells against Acrolein-Induced Oxidative Injury
Marine Drugs · 2023
DOI: 10.3390/md21030137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Cheng Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Key Laboratory of Glycoscience and Glycotechnology, Key Laboratory of Marine Drugs of Ministry of Education, School of Medicine and Pharmacy…. Hauptthemen laut MEDLINE: Antioxidants, Macular Degeneration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Major Science and Technology Project, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Age-related macular degeneration (AMD) is the leading cause of vision loss among the elderly. The progression of AMD is closely related to oxidative stress in the retinal pigment epithelium (RPE). Here, a series of chitosan oligosaccharides (COSs) and N-acetylated derivatives (NACOSs) were prepared, and their protective effects on an acrolein-induced oxidative stress model of ARPE-19 were explored using the MTT assay. The results showed that COSs and NACOs alleviated APRE-19 cell damage induced by acrolein in a concentration-dependent manner. Among these, chitopentaose (COS–5) and its N-acetylated derivative (N–5) showed the best protective activity. Pretreatment with COS–5 or N–5 could reduce intracellular and mitochondrial reactive oxygen species (ROS) production induced by acrolein, increase mitochondrial membrane potential, GSH level, and the enzymatic activity of SOD and GSH-Px. Further study indicated that N–5 increased the level of nuclear Nrf2 and the expression of downstream antioxidant enzymes. This study revealed that COSs and NACOSs reduced the degeneration and apoptosis of retinal pigment epithelial cells by enhancing antioxidant capacity, suggesting that they have the potential to be developed into novel protective agents for AMD treatment and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Key Laboratory of Glycoscience and Glycotechnology, Key Laboratory of Marine Drugs of Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao 266237, China.
- Laboratory of Marine Glycodrug Research and Development, Marine Biomedical Research Institute of Qingdao, Qingdao 266071, China.
ORCID-Profile: Chunxia Li
Förderung
- National Natural Science Foundation of China
- Shandong Major Science and Technology Project
- Shandong Provincial Natural Science Foundation
- National Science and Technology Major Project for Significant New Drugs Development
- programs of the Shandong Major Science and Technology Project
Zitieren
APA
Yang, C., Yang, R., Gu, M., Hao, J., Wang, S., & Li, C. (2023). Chitooligosaccharides Derivatives Protect ARPE-19 Cells against Acrolein-Induced Oxidative Injury. Marine Drugs. https://doi.org/10.3390/md21030137
Vancouver
Yang C, Yang R, Gu M, Hao J, Wang S, Li C. Chitooligosaccharides Derivatives Protect ARPE-19 Cells against Acrolein-Induced Oxidative Injury. Marine Drugs. 2023. doi:10.3390/md21030137
BibTeX
@article{Yang2023,
author = {Yang, Cheng and Yang, Rongrong and Gu, Ming and Hao, Jiejie and Wang, Shixin and Li, Chunxia},
title = {Chitooligosaccharides Derivatives Protect ARPE-19 Cells against Acrolein-Induced Oxidative Injury},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21030137}
}
EUVIMED